Apoptosis Antibodies
Apoptosis refers to the set of ordered biochemical and physical changes in a cell during a specific form of cell death. These changes begin with the rounding and shrinking of the affected cells causing them to lose contact with their neighbors. Later, their endoplasmic reticulum swells and the cisternae begin to form vesicles and vacuoles. In the nucleus, the chromatin condenses and is digested by endogenous nucleases. The nucleus ultimately disintegrates into fragments which are encapsulated into apoptotic bodies. By this point, the plasma membrane has become convoluted and begins blebbing off, forming the surface of the apoptotic bodies, which are then recognized and engulfed by phagocytic cells. In contrast, during necrosis the cell swells and disintegrates in a disordered manner, leading to the destruction of cellular organelles and the rupture of the plasma membrane.
ProSci has a wide variety of apoptosis antibodies. These include antibodies against p53 upregulated modulator of apoptosis (PUMA), Bim, members of the caspase family, death receptors, p53 and many other apoptosis proteins. Additionally, ProSci offers a BAFF and Receptor Detection Set and a TRAIL and Receptor Detection set. ProSci antibodies are appropriate for ELISA, western blot, and immunohistochemistry (IHC) applications as noted for each apoptosis antibody.
Also, we have a TRAIL and TRAIL receptor flyer in the posters section of our resources area of the ProSci website and our TRAIL and TRAIL receptor products were featured in our May 2006 newsletter which is also in the posters section of our resources area.
Apoptosis Antibodies from ProSci:
| Product Name | Catalog # | App. | Reactivity | Description |
|---|---|---|---|---|
| TACE Antibody | 1131 | E, WB, ICC, IF, FACS | H, M, R | (CT) TNFalpha converting enzyme |
| TACI Antibody | XP-5278 | E, WB | H | Anti-Human TACI |
| TACI Antibody | XP-5278Bt | E, WB | H | Biotin - Anti-Human TACI |
| TACI Antibody | 2395 | E, WB, ICC | H | (NT) Receptor for BAFF and APRIL |
| TCCR Antibody | 2481 | E, WB, IHC, IF | H | (NT) A new T cell cytokine receptor |
| TCCR Antibody | 2483 | E, WB, IHC, IF | H | (CT) A new T cell cytokine receptor |
| TGFb1 Antibody | XG-6171 | E, WB | H | Anti-TGFβ1 |
| TGM2 Antibody | 51-098 | WB, IHC, IP | M, R | Transglutaminase 2 |
| TGM2 Monoclonal Antibody | 51-055 | E, WB, IHC, IP | n/a | Transglutaminase 2 |
| TGM5 Antibody | 6537 | E, WB, IHC, IF | H, M, R | (CT) Transglutaminase 5 |
| TGM6 Antibody | 6539 | E, WB, IHC, IF | H, M, R | (CT) Transglutaminase 6 |
| TGM7 Antibody | 6541 | E, WB, ICC, IF | H, M | (IN) Transglutaminase 7 |
| THEM4 Antibody | 5227 | E, WB, IHC, IF | H, M, R | (IN) Thioesterase superfamily member 4 |
| TIA1 Antibody | 25-657 | E, WB | H, M | TIA1 (TIA1 cytotoxic granule-associated RNA bindin |
| TIAF Antibody | 7305 | E, WB | H, M | (NT) TGFB1-induced anti-apoptotic factor 1 |
| TIAF1 Antibody | XW-7747 | WB | H | TGFB1-induced anti-apoptotic factor 1 |
| TIAL1 Antibody | 31-020 | E, WB | H, D | TIAL1 (TIA1 cytotoxic granule-associated RNA bindi |
| TIGAR Antibody | 4051 | E, WB, IHC, IF | H, M | (IN2) p53-induced glycolysis and apoptosis regulat |
| TIGAR Antibody | 4049 | E, WB, IHC | H, M, R | (IN1) p53-induced glycolysis and apoptosis regulat |
| TIPARP Antibody | 25-160 | E, WB | H | TIPARP (TCDD-inducible poly (ADP-ribose) polymeras |
| TL1A Antibody | 3789 | E, WB | H, M | DR3 ligand |
| TL1A Antibody | 3109 | E, WB | H, M, R | (NT) DR3 ligand |
| TNFRSF10A Antibody | 31-027 | E, WB | H | TNFRSF10A (tumor necrosis factor receptor superfam |
| TNFRSF10B Antibody | 49-325 | WB, IHC, ICC, FACS | H | Biotein - Tumor Necrosis Factor Receptor Superfami |
| TNFRSF11B Antibody | 31-004 | E, WB | H | TNFRSF11B (tumor necrosis factor receptor superfam |
| TNFRSF18 Antibody | 31-022 | E, WB | H | TNFRSF18 (tumor necrosis factor receptor superfami |
| TNFRSF18 Antibody | 31-021 | E, WB, IHC | H | TNFRSF18 (tumor necrosis factor receptor superfami |
| TNFRSF19 Antibody | 49-330 | WB, IHC | M | Tumor Necrosis Factor Receptor Superfamily |
| TNFRSF1A Antibody | 51-016 | WB, IHC | M, R, Rb, P, B, HM, Mk | Tumor Necrosis Factor Receptor Superfamily, Member |
| TNFRSF1B Antibody | 48-598 | WB, IHC | H, R | (CT) Tumor Necrosis Factor Receptor Superfamily |
| Tnfrsf1b Antibody | 42-318 | E, WB | M, R | (IN) TNF-R-II / TNFR2 (mouse) |
| TNFRSF8 Monoclonal Antibody | 49-104 | IHC, FACS | H | Tumor Necrosis Factor Receptor Superfamily |
| TNFSF10 Antibody | 31-018 | E, WB | H | TNFSF10 (tumor necrosis factor (ligand) superfamil |
| TNFSF12 Antibody | 25-364 | E, WB | H | TNFSF12 (tumor necrosis factor (ligand) superfamil |
| TNKS Antibody | 25-159 | E, WB | H, M | TNKS (tankyrase, TRF1-interacting ankyrin-related |
| TNKS Antibody | 25-158 | E, WB | H | TNKS (tankyrase, TRF1-interacting ankyrin-related |
| Tollip (MAb Kimmy-1) Antibody | XA-1010 | WB, IP | M, H | monoclonal to Tollip (Kimmy-1) |
| Tollip (MAb Kimmy-2) Antibody | XA-1022 | WB, IP | H, M | monoclonal to Tollip (Kimmy-2) |
| Toso Antibody | 2273 | E, WB | H | (CT) a regulator of the death-inducing signaling c |
| TP53 Antibody | 31-024 | E, WB | H | TP53 (tumor protein p53 (Li-Fraumeni syndrome)) |
| TP53BP1 Antibody | 48-864 | WB, IHC | H | Tumor Protein P53 Binding Protein |
| TP53I11 Antibody | 49-745 | E, IHC | H | Tumor Protein P53 Inducible Protein 11 |
| TP73 Antibody | 28-910 | E, WB | H | TP73 (tumor protein p73) |
| TPTE Antibody | 28-558 | E, WB | H | TPTE (transmembrane phosphatase with tensin homolo |
| TPTE Antibody | 28-559 | E, WB, IHC | H | TPTE (transmembrane phosphatase with tensin homolo |
| TRADD Antibody | 48-632 | WB, IHC | H | (CT) Tnfrsf1a-associated Via Death Domain |
| TRAF2 Monoclonal Antibody | 49-339 | WB, IHC | H | Biotin - TNF Receptor-associated Factor 2 |
| TRAF4 Antibody | 27-221 | E, WB | H, M, R | TRAF4 (TNF receptor-associated factor 4) |
| TRAIL and Receptor Detection Set | PSI-1801 | WB, IHC | see datasheet | TRAIL, DR4, DR5, DcR1, DcR2 |
| Trail Antibody | 1113 | E, WB, IHC | H | (CT) Ligand for DR4 and DR5 |

